Abstract:Introduction: This study aimed to elucidate the coagulation disorders in non-ICU patients with acute kidney injury (AKI) and their contribution to clotting-related outcomes of intermittent kidney replacement therapy (KRT). Methods: We included non-ICU-admitted patients with AKI requiring intermittent KRT, clinically having a risk of bleeding and against systemic anticoagulant use during KRT between April and December 2018. The premature termination of treatment due to circuit clotting was considered a poor outcome. We analyzed the characteristics of thromboelastography (TEG)-derived and traditional coagulation parameters and explored the potential-affecting factors. Results: In total, 64 patients were enrolled. Hypocoagulability was detected in 4.7%-15.6% of patients by a combination of the traditional parameters, i.e., prothrombin time (PT)/international normalized ratio, activated partial PT, and fibrinogen. No patient had hypocoagulability observed on TEG-derived reaction time; only 2.1%, 3.1%, and 10.9% of patients had hypocoagulability on TEG-derived kinetic time (K-time), α-angle, and maximum amplitude (MA), respectively, which were also platelet-related coagulation parameters, despite 37.5% of the cohort having thrombocytopenia. In contrast, hypercoagulability was more prevalent, involving 12.5%, 43.8%, 21.9%, and 48.4% of patients on TEG K-time, α-angle, MA, and coagulation index (CI), respectively, although thrombocytosis was only in 1.5% of the cohort. Patients with thrombocytopenia showed lower fibrinogen level (2.6 vs. 4.0 g/L, p = 0.00), α-angle (63.5° vs. 73.3°, p = 0.00), MA (53.5 vs. 66.1 mm, p = 0.00), and CI (1.8 vs. 3.6, p = 0.00) but higher thrombin time (17.8 vs. 16.2 s, p = 0.00) and K-time (2.0 vs. 1.2 min, p = 0.00) than those with a platelet count over 100 × 109/L. 41 patients were treated with heparin-free protocol, and 23 were treated with regional citrate anticoagulation (RCA). The premature termination rate was 41.5% on heparin-free patients, while 8.7% of patients underwent an RCA protocol (p = 0.006). Heparin-free protocol was the strongest adverse factor to poor outcomes. A heparin-free subgroup analysis found that the circuit clotting risk was increased by 61.7% with a 10 × 109/L elevation in platelet count (odds ratio [OR] = 1.617, p = 0.049) and decreased by 67.5% following a second increase of PT (OR = 0.325, p = 0.041). No significant correlation was found between TEG parameters and premature circuit clotting. Conclusions: Most non-ICU-admitted patients with AKI had normal-to-enhanced hemostasis and activated platelet function based on TEG results, as well as a high rate of premature circuit clotting when receiving heparin-free protocol despite thrombocytopenia. Further studies are needed to better determine the use of TEG in respect to management of anticoagulation and bleeding complications in AKI patients with KRT.

Thrombelastography and coagulation parameters in chronic kidney disease patients and theirs clinical significance

A comparative study on thrombelastography and routine coagulation tests in chronic renal diseases

Risk Factors Analysis of Hypercoagulability in Patients with Chronic Kidney Disease by Thrombelastograph

Blood coagulation system in patients with chronic kidney disease: a prospective observational study

Thromboelastography and Traditional Coagulation Testing in Non-ICU-Admitted Patients with Acute Kidney Injury: An Observational Cohort Study

Characterization of Thromboelastography of Patients with Different Pathological Types of Nephrotic Syndrome

Risk factor prediction of severe postoperative acute kidney injury at stage 3 in patients with acute type A aortic dissection using thromboelastography

Spontaneous bleeding in chronic kidney disease: global coagulation assays may predict bleeding risk

Assessment of Hypercoagulability Using Thromboelastography Predicts Advanced Status in Renal Cell Carcinoma.

Characterization of Soluble Thrombomodulin Levels in Patients with Stage 3–5 Chronic Kidney Disease

Effect of thromboelastography on coagulation states evaluation in patients with decompensated cirrhosis

The association of coagulation indicators with in-hospital acute kidney injury and malignant events of patients with acute aortic dissection: a retrospective cohort study

Value of Thromboelastography Combined with Anticoagulant Detection in Patients over 60 Years of Age with Cardiovascular or Cerebrovascular Disease.

Thrombelastography And Coagulation Parameters In Septic Patients And Their Clinical Significance

Evaluating Hypercoagulability in New-Onset Systemic Lupus Erythematosus Patients Using Thromboelastography.

Von Willebrand Factor, ADAMTS13 Activity, TNF-α and Their Relationships in Patients with Chronic Kidney Disease.

Von Willebrand Factor, ADAMTS13 Activity, TNF-Alpha, and Their Relationships in Patients with Chronic Kidney Disease

Coagulation Parameters Are Associated with the Prognosis of Immunoglobulin a Nephropathy: a Retrospective Study

Effects of hemolysis and lipemia interference on kaolin-activated thromboelastography, and comparison with conventional coagulation tests

Regulation of Coagulation Function in Patients with Cirrhosis Splenectomy by Thromboelastography

[New markers of cardio-renal links in chronic kidney disease]